Key result
In patients undergoing radiofrequency ablation for atrial fibrillation, overweight and obesity were associated with longer procedure duration (MD 0.95) and higher radiation dose, but not complications.
Why the study?
The association of body mass index and procedure-related factors in patients with AF after radiofrequency ablation was unclear.
Does overweight or obesity increase procedure duration, radiation dose, and procedural complications in patients with atrial fibrillation undergoing radiofrequency ablation compared to normal BMI?
Meta-Analysis (n=14,735)
Does overweight or obesity increase procedure duration, radiation dose, and procedural complications in patients with atrial fibrillation undergoing radiofrequency ablation compared to normal BMI?
Mean Difference: 0.95
In patients undergoing radiofrequency ablation for atrial fibrillation, overweight and obesity are associated with longer procedure times and higher radiation doses, but not with an increased risk of procedural complications.
May inform procedural planning and radiation safety in overweight AF ablation patients; extends meta-analytic evidence on body habitus effects.
BACKGROUND: The association of body mass index (BMI) and procedure-related factors in patients with atrial fibrillation (AF) after radiofrequency ablation (RFA) is still unclear. HYPOTHESIS: BMI is associated with increased the radiation dose, procedure duration, and procedural complications. METHODS: Prospective studies assessing BMI and procedure duration, radiation dose, and procedural complications in patients with AF after RFA were identified through electronic searches of PubMed, Embase, and the Cochrane Library database. RESULTS: Ten studies with 14 735 participants undergoing RFA were included. Procedure duration was significantly longer in patients with overweight or obesity than in patients with normal BMI, with a mean difference (MD) of 0.95. Patients with overweight and obesity were exposed to a larger radiation dose, with standard MD of 1.71 and 1.98, respectively. There was no significant association between overweight or obesity and the risk of procedural complications (RR of 0.91 for overweight, 1.01 for obesity, 0.89 for stage I obesity, 1.00 for stage II obesity, and 0.94 for stage III obesity). Further analysis showed there was no significant difference regarding stroke or transient ischemic attack (overweight, RR: 0.92; obesity, RR: 1.02); cardiac tamponade (overweight, RR: 0.92; obesity, RR: 1.02); groin hematoma (overweight, RR: 0.62; obesity, RR: 0.40); or pulmonary vein stenosis (overweight, RR: 0.49; obesity, RR: 0.40) among BMI groups. CONCLUSION: Based on available evidence, we first showed that patients with overweight/obesity undergoing RFA experienced a significantly increased procedure duration and received a larger radiation dose than patients with normal BMI; however, there was no significant difference in procedural complications between patients with overweight/obesity and patients with normal BMI.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2020) conducted a meta-analysis in Atrial fibrillation (n=14,735). Overweight or obesity (high BMI) vs. Normal BMI was evaluated on Procedure duration (MD 0.95). In patients undergoing radiofrequency ablation for atrial fibrillation, overweight and obesity were associated with longer procedure duration (MD 0.95) and higher radiation dose, but not complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: